Heart to Heart Nurses

Nancy Albert, APN, and Rimsky Denis, MD discuss current studies in ASCVD risk reduction for patients with--or at risk for--Type 2 Diabetes. Thay also describe strategies for shared decision-making in clinical practice for managing both cardiovascular disease and diabetes.  CE LINK: pcna.net/podcast/understanding-and-reducing-cardiovascular-and-cardiometabolic-risks American Heart Association,...

The available novel diabetes therapies and their impact on cardiovascular and cardiometabolic risk reduction are discussed by guests Chris Memering, MSN, RN, CDCES, BC-ADM, FADCES, and Sun Kim, MD. A particular emphasis on GLP-1 receptor agonists, and the patients for whom they are guideline recommended, as well as ongoing research are also covered. CE LINK: pcna.net/podcast/novel-diabetes-therapi...

Utilizing team- and patient-based care makes a significant impact on our patients, including those with hypertension and diabetes. Guest Thomas Hinneh, MScIH, BScN, RN, shares his experience and inspiration from his work in Ghana, with takeaways we all can utilize in clinical practice. PCNA diabetes tools for patients: https://pcna.net/clinical-resources/patient-handouts/diabetes-tools-and-handout...

Take 1 minute to tell us what you think about this episode: pcna.net/PSVTeval Guest Mary Janette Sendin, MSN, APRN-CNS, CCNS, PCCN describes traditional pharmacologic and non-pharmacologic treatment options for PSVT such as vasovagal technique. Janette also discusses current research into treatment options. ESC Guideline: Brugada J, Katritsis DG, Arbelo E, et al. 2019 ESC Guidelines for the manage...

Take 1 minute to tell us what you think about this episode: pcna.net/PSVTeval Guests Mary Janette Sendin, MSN, APRN-CNS, CCNS, PCCN, and Daniel Weinstein discuss the patient journey for those with PSVT, and the challenges that can delay diagnosis for some individuals. The importance of patient-centered care in the healthcare setting and beyond is also part of the conversation. See Privacy Policy a...

Take 1 minute to tell us what you think about this episode: pcna.net/PSVTeval Kathryn Wood, PhD, RN, FAHA, FAAN, discusses paroxysmal supraventricular tachycardia (PSVT) and other similar episodic rapid heart rate conditions. Dr. Wood describes pathophysiology, prevalence, symptoms, and disparities related to diagnosis and treatments, and also shares helpful resources for both providers and patien...

Health inequities affect a variety of health issues, including the chronic condition of obesity. In this episode, learn about the disparate impacts of social determinants of health (SDOH) on obesity. Guests Yvonne Commodore Mensah, PhD, MHS, RN, & Tiffany Powell-Wiley MD, MPH, also investigate how adoption of a holistic approach can positively impact obesity treatment, and how activating commu...

How do we effectively address the increasing strain on an already overwhelmed workforce? Guests Nikki Akparewa, RN, MSN/MPH, and Michelle Johnson, MD, MPH, describe how burnout, turnover, and early retirement are impacting health care professionals, and how training and education can lead to a better workplace. Recorded in partnership with Medical Alley and the Association of Black Cardiologists....

Guests Rimsky Denis, MD, MPH, MBA, and Ms. Sam Hoeffler discuss community-based strategies for improving health outcomes and promoting health equity. Specific initiatives include health fairs, barbershops, increasing communication in disenfranchised communities, improving outcomes in hypertension, and increasing access to healthy food. Recorded in partnership with Medical Alley and the Association...

[CE contact hours--see below.]: Guest Cindy Lamendola, MSN, NP, FAHA, FPCNA, describes the impacts of elevated Lp(a) on the body. Current clinical trials, and the necessity of including diverse participants are described, as well as the importance of keeping Lp(a) front of mind no matter our role as healthcare professionals. CE LINK: https://pcna.net/online-course/ce-podcast-were-all-responsible-f...

[CE contact hours--see below.] While Lp(a) levels are generally hereditary in nature, other factors can cause elevated levels. Learn about current guidelines-directed medical therapies, and how guests Lisa Maher, DNP, ARNP, FNP-BC, FPCNA, and Kathy Byrne, MSN, CRNP, CCRN. apply these guidelines into clinical practice. CE LINK: https://pcna.net/online-course/ce-podcast-lurking-lpa-hiding-just-below...

[CE contact hours--see below.] : Guests Kathy Byrne, MSN, CRNP, CCRN.,and Lisa Maher, DNP, ARNP, FNP-BC, FPCNA, describe the most common genetic dyslipidemia--elevated lipoprotein (a), or Lp(a). The discussion includes testing for Lp(a)--especially for family members, and others who may be at risk. Resources for patients and HCPs are also part of the conversation. CE LINK:https://pcna.net/online-c...

Only 20% of patients with atrial fibrillation are symptomatic for all their AFib episodes. Guest Dan Sorajja, MD, FACC, FHRS describes AFib diagnosis and patient-based treatment decisions for AFib. Dr. Sorajja also discusses Long QT Syndrome and team-based care. PCNA AFib patient tools:  https://pcna.net/clinical-resources/patient-handouts/atrial-fibrillation-tools-and-handouts/ PCNA HCP tool...

Applying guidelines-directed therapies for antiplatelets and antithrombotics requires balancing the risks of cardiovascular events and the risk of bleeding. Guest Erin Michos, MD, MHS, FACC, FAHA, FASE, FASCP, describes the use shared decision-making with patients who are at higher risk for thrombotic events, and discusses pharmacotherapies recommended for use with particular patient groups. 2019...

An estimated 8.5 million adults over the age of 40 have PAD, yet up to half have no symptoms. Guest Lola Coke, PhD, ACNS-BC, FAHA, FPCNA, FAAN, describes how the disease disproportionately impacts individuals who are Black, Latinx, and Native American, and how clinician awareness can make a positive difference in effective diagnosis and management. PAD Patient education tools (PCNA): https://pcna....

Hypertrophic Cardiomyopathy (HCM) is the most common genetic heart condition. Typical symptoms, testing, and treatment options are discussed, as well as the role of genetic counseling and referrals to a Center of Excellence in HCM team-based care. Guest: Heidi Salisbury, RN, MSN, CNS-BC, ACGN. Hypertrophic Cardiomyopathy Association: https://4hcm.org/ HCM Centers of Excellence: https://4hcm.org/ce...

The assessment and treatment of chest pain--both acute and chronic--is the focus of this conversation with guest Debabrata Mukherjee, MD. Dr. Mukherjee describes risk stratification, appropriate testing, and shared decision-making with patients with chest pain, as well as the importance of preventive care. The HEART score: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6005932/ 2021 Chest Pain Guide...

Stephanie Little, MSN, RNC-OB, C-EFM, examines cardio-obstetrics, a growing field focused on the link of CVD in patients who are pregnant, post-partum, or have had pregnancy-related health issues. The conversation also includes information about professional development throughout the nursing career, and a review of the importance of nutrition on heart health. PCNA CE Course: https://pcna.net/onli...

In the final of this three-part content series join colleagues Amy Chybowski, NP and Jonathan Milton, MA, BSN, RN, CCRN-CMC as they discuss the different treatment pathways for patients with pulmonary hypertension (PH). Learn about the three different treatment options and the important role of team-based care. Pulmonary Hypertension Association Patient Resources https://phassociation.org/patients...

In this second episode of a three-part content series on pulmonary hypertension (PH) we sit down with Raza Farhan, MD and discuss the diagnosis journey of PH. Dr. Raza describes the nuances behind PH WHO groups and dives into right heart catheterizations. Performance and Interpretation of Invasive Hemodynamic Exercise Testing https://www.sciencedirect.com/science/article/a...

Hear from guests Traci Housten, RN, MS and Lisa Maher, DNP, ARNP, FNP-BC, FPCNA in the first episode of this three-part content series on pulmonary hypertension (PH). Traci and Lisa discuss the complexity around recognizing PH from both the general cardiology and specialty clinician standpoint and dive into what providers should be on the lookout for and which tests can be ordered. They...

Hypertension prevention and management is a keystone strategy in reducing CVD risk globally, and guest Eileen Handberg, PhD, ANP-BC, FAHA, FACC, FPCNA, compels nurses to continue to play key leadership roles in this endeavor. Dr. Handberg also shares the importance of involvement in professional associations. PCNA patient ed tools: https://pcna.net/clinical-resources/patient-handouts/hypertension-...

Guest Cindy Lamendola, MSN, NP, FAHA, FPCNA, describes the connections between CVD and diabetes, and related tools for both health care professionals (HCPs) and patients. Cindy also discusses clinical trials, and the role each HCP plays in ensuring representation by diverse populations.  Global Heart Hub: https://globalhearthub.org/  Know Diabetes by Heart: https://www.knowdiabetesbyhear...

Improving outcomes for patients with CVD requires team-based care and effectively addressing multiple risk factors. Guest Barbara Fletcher, RN, MN, FAHA, FPCNA, FAAN, highlights prevention strategies, and how nurses across the globe can learn from the Cardiovascular Nursing Certificate program.  AHA Heart Disease & Stroke Statistics (2023): https://www.ahajournals.org/doi/10.1161/CIR.0000...

With 3/4 of adults, 4/5 of elderly individuals and 1/3 of children taking dietary supplements, it is imperative that health care professionals understand what their patients are ingesting and why, and how this may affect other treatments, including for CVD. Guest Rhonda Cooper-DeHoff, PharmD, also addresses cannabinoids, and resources to help you and your patients navigate the sea of dietary suppl...